{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:50:32Z","timestamp":1769629832842,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Persons who are infected with human immunodeficiency virus (HIV) are at high risk of human papillomavirus (HPV)-associated cancers. The objectives are to compare antibody titers to HPV 6, 11, 16, and 18 and rate of abnormal cytology between perinatally HIV-infected (PHIV) and perinatally HIV-exposed, uninfected (PHEU) youth.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a prospective observational cohort study of HPV4 vaccinated youth performed as part of the multicenter Pediatric HIV\/AIDS Cohort Study Adolescent Master Protocol. Seroconversion and geometric mean titer (GMT) against HPV types 6, 11, 16, and 18 were calculated. Vaccine effectiveness included rates of abnormal cervical cytology and genital warts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seroconversion to HPV 6, 11, 16, and 18 occurred in 83%, 84%, 90%, and 62% of 310 vaccinated PHIV youth compared to 94%, 96%, 99%, and 87% of 148 vaccinated PHEU youth, respectively (P &amp;lt; .05 for all comparisons). GMTs were lower in the PHIV vs PHEU within each category of HPV4 doses received. Higher GMTs were associated with younger age, lower HIV type 1 RNA viral load, and higher CD4% at first HPV4 vaccination, as well as shorter duration between last vaccine dose and antibody specimen. Abnormal cytology occurred in 33 of 56 PHIV and 1 of 7 PHEU sexually active vaccinated females, yielding incidence rates per 100 person-years of 15.0 (10.9 to 20.6) and 2.9 (0.4 to 22.3), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Antibody titers to HPV4 were lower for all serotypes in PHIV compared to PHEU youth. Protection against abnormal cytology was also diminished in sexually active PHIV females.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciy1040","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T12:56:56Z","timestamp":1551877016000},"page":"1183-1191","source":"Crossref","is-referenced-by-count":26,"title":["Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus\u2013infected and Exposed, Uninfected Youth"],"prefix":"10.1093","volume":"69","author":[{"given":"Anna-Barbara","family":"Moscicki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Adolescent Medicine, University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad","family":"Karalius","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Tassiopoulos","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzy-Jyun","family":"Yao","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise L","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunjal","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murli","family":"Purswani","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, Bronx-Lebanon Hospital Center, Icahn School of Medicine at Mount Sinai, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"George R","family":"Seage","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Pediatric HIV\/AIDS Cohort Study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Yogev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret Ann","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Malee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Shearer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynnette","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murli","family":"Purswani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboobullah Mirza","family":"Baig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Puga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A","family":"Garvie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Blood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra K","family":"Burchett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Karthas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Kammerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wiznia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Burey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphaelle","family":"Auguste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arry","family":"Dieudonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Bettica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Garcia","family":"Bulkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latreaca","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitzie","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Allison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Russell-Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midnela","family":"Acevedo-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heida","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Silio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medea","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Sirois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A","family":"Spector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Cagwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa","family":"Katai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwendolyn","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anai","family":"Cuadra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"2019123108581817000_CIT0001","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"key":"2019123108581817000_CIT0002","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1016\/j.vaccine.2008.09.073","article-title":"HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine","volume":"26","author":"Joura","year":"2008","journal-title":"Vaccine"},{"key":"2019123108581817000_CIT0003","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"2019123108581817000_CIT0004","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2019123108581817000_CIT0005","doi-asserted-by":"crossref","first-page":"g1458","DOI":"10.1136\/bmj.g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"key":"2019123108581817000_CIT0006","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncol"},{"key":"2019123108581817000_CIT0007","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/INF.0b013e31819d31bc","article-title":"Vaccination in the immunocompromised child: a probe of immune reconstitution","volume":"28","author":"Abzug","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2019123108581817000_CIT0008","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/cid\/civ440","article-title":"Immunity to measles, mumps, and rubella in US children with perinatal HIV infection or perinatal HIV exposure without infection","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019123108581817000_CIT0009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/civ734","article-title":"Prevalence and persistence of varicella antibodies in previously immunized children and youth with perinatal HIV-1 infection","volume":"62","author":"Purswani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019123108581817000_CIT0010","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"2019123108581817000_CIT0011","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.soc.2016.07.010","article-title":"Human immunodeficiency virus\/AIDS, human papillomavirus, and anal cancer","volume":"26","author":"Wang","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"key":"2019123108581817000_CIT0012","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0b013e3181de8d26","article-title":"Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old","volume":"55","author":"Levin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019123108581817000_CIT0013","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/jis489","article-title":"Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children","volume":"206","author":"Weinberg","year":"2012","journal-title":"J Infect Dis"},{"key":"2019123108581817000_CIT0014","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.vaccine.2017.02.021","article-title":"Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: effect of a fourth dose of vaccine","volume":"35","author":"Levin","year":"2017","journal-title":"Vaccine"},{"key":"2019123108581817000_CIT0015","volume-title":"2-dose vs. 3-dose HPV vaccination: can a 2-dose strategy be the best use of resources?","author":"Jit","year":"2012"},{"key":"2019123108581817000_CIT0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/QAI.0b013e318215c7b1","article-title":"Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes","volume":"57","author":"Van Dyke","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019123108581817000_CIT0017","doi-asserted-by":"crossref","first-page":"e011396","DOI":"10.1136\/bmjopen-2016-011396","article-title":"Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study","volume":"6","author":"Tassiopoulos","year":"2016","journal-title":"BMJ Open"},{"key":"2019123108581817000_CIT0018","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/cid\/cis816","article-title":"Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development","volume":"56","author":"Tassiopoulos","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019123108581817000_CIT0019","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/CDLI.12.8.959-969.2005","article-title":"Optimization and validation of a multiplexed Luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18","volume":"12","author":"Dias","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2019123108581817000_CIT0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/CDLI.10.1.108-115.2003","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"2019123108581817000_CIT0021","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/CVI.00348-09","article-title":"Multiplexed serologic assay for nine anogenital human papillomavirus types","volume":"17","author":"Opalka","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2019123108581817000_CIT0022","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"key":"2019123108581817000_CIT0023","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"2019123108581817000_CIT0024","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jnci\/djr319","article-title":"Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16\/18 vaccine","volume":"103","author":"Kreimer","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2019123108581817000_CIT0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(15)00414-3","article-title":"Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study","volume":"17","author":"Sankaranarayanan","year":"2016","journal-title":"Lancet Oncol"},{"key":"2019123108581817000_CIT0026","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2013.1625","article-title":"Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial","volume":"309","author":"Dobson","year":"2013","journal-title":"JAMA"},{"key":"2019123108581817000_CIT0027","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0000000000001355","article-title":"Brief report: antibody responses to quadrivalent HPV vaccination in HIV-infected young women as measured by total IgG and competitive Luminex immunoassay","volume":"75","author":"Kahn","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2019123108581817000_CIT0028","first-page":"61","article-title":"Immunization of children at risk of infection with human immunodeficiency virus","volume":"81","author":"Moss","year":"2003","journal-title":"Bull World Health Organ"},{"key":"2019123108581817000_CIT0029","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/j.vaccine.2014.08.011","article-title":"Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults","volume":"32","author":"Giacomet","year":"2014","journal-title":"Vaccine"},{"key":"2019123108581817000_CIT0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/cid\/ciu238","article-title":"Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women","volume":"59","author":"Kojic","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019123108581817000_CIT0031","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2105\/AJPH.2005.071910","article-title":"Reproductive health of adolescent girls perinatally infected with HIV","volume":"97","author":"Brogly","year":"2007","journal-title":"Am J Public Health"},{"key":"2019123108581817000_CIT0032","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JCM.43.1.376-381.2005","article-title":"Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland","volume":"43","author":"Rintala","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2019123108581817000_CIT0033","doi-asserted-by":"crossref","first-page":"326369","DOI":"10.1155\/2010\/326369","article-title":"Evidence for vertical transmission of HPV from mothers to infants","volume":"2010","author":"Smith","year":"2010","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2019123108581817000_CIT0034","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2334-9-74","article-title":"Human papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain","volume":"9","author":"Castellsagu\u00e9","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2019123108581817000_CIT0035","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1086\/498114","article-title":"High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study","volume":"41","author":"Rintala","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019123108581817000_CIT0036","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.semdp.2017.04.005","article-title":"Pathobiology of human papillomaviruses in human immunodeficiency virus-infected persons","volume":"34","author":"Krishnamurti","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"2019123108581817000_CIT0037","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/apc.2013.0313","article-title":"Human papillomavirus infections in nonsexually active perinatally HIV infected children","volume":"28","author":"Moscicki","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"2019123108581817000_CIT0038","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1073\/pnas.1202684109","article-title":"A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer","volume":"109","author":"Herfs","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019123108581817000_CIT0039","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.molmed.2016.09.002","article-title":"Modulating antibody functionality in infectious disease and vaccination","volume":"22","author":"Gunn","year":"2016","journal-title":"Trends Mol Med"},{"key":"2019123108581817000_CIT0040","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.4049\/jimmunol.1601197","article-title":"Diversity of antiviral IgG effector activities observed in HIV-infected and vaccinated subjects","volume":"197","author":"Huang","year":"2016","journal-title":"J Immunol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/7\/1183\/31666226\/ciy1040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/7\/1183\/31666226\/ciy1040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T09:16:58Z","timestamp":1606641418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/7\/1183\/5423927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,2,21]]},"published-print":{"date-parts":[[2019,9,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy1040","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10,1]]},"published":{"date-parts":[[2019,2,21]]}}}